Brain Cancer Trial, Recruiting NCT05659524 Sponsor: Lori Wood Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT05659524
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are an adult who is scheduled to have endoscopic (minimally invasive, through the nose) surgery to remove a pituitary tumor, including non-functioning adenoma, acromegaly-related tumors, prolactinoma, or Rathke's cleft cyst
  • You are between 18 and 85 years old
  • You speak English and are able to complete two specific nasal/sinus symptom questionnaires (called ASK Nasal-12 and SNOT-22)
  • You do not have any physical, mental, or medical condition that the study doctor feels would make it unsafe or unsuitable for you to take part
  • Your planned surgery will go through both nostrils
  • You may or may not need a tissue flap used to repair the surgical area
  • You may or may not need a procedure to straighten the wall inside your nose (septoplasty)

Who may not be able to join:

  • You currently have an active sinus infection or active sinusitis
  • You have allergic rhinitis (hay fever or nasal allergies)
  • You have asthma
  • You have a vascular (blood vessel) or inflammatory disease
  • You have had previous surgery on your sinuses or nasal passages
  • You are unwilling or unable to sign a consent form for the study
  • You are pregnant
  • You are currently incarcerated
  • You have Cushing's disease
  • You have a history of chronic (long-term) sinusitis
  • Your surgery involves a more complex, extended approach to the base of the skull (confirm with trial site)
  • You have nasal polyps (small growths inside the nose)
  • You are currently taking antibiotics for another condition (for example, a urinary tract infection)
  • You have a weakened immune system or immune deficiency condition
  • You have previously had radiation treatment to the base of your skull

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 602-406-8772

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lori Wood
Registry
ClinicalTrials.gov
Start date
18 December 2020
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difference in mean sinonasal quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov